Codes / ICD10CM / T50.99

T50.99 Poisoning by, adverse effect of and underdosing of other drugs, medicaments and biological substances

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of other drugs, medicaments and biological substances (ICD-10 Code: T50.99)

Summary

This condition involves harmful effects resulting from exposure to drugs, medicaments, or biological substances that are categorized as "other" (not specified elsewhere in the ICD-10-CM classification). It includes poisoning, adverse reactions, or underdosing scenarios, with the exact nature of the event (e.g., accidental, intentional, or therapeutic error) influencing clinical presentation and management. The term "other" indicates the substance is not classified under more specific codes.

Causes

Exposure to other drugs or biological substances can occur through accidental ingestion, therapeutic error (e.g., incorrect dosing), intentional misuse, or adverse reactions to prescribed medications. The cause may be unknown or unspecified, particularly in cases of underdosing or unreported adverse effects involving substances not covered by more detailed codes.

Risk Factors

  • Concurrent use of multiple medications increasing interaction risk
  • History of substance misuse or self-harm behaviors
  • Lack of supervision in medication administration (e.g., in vulnerable populations)
  • Underlying conditions requiring drug therapy
  • Polypharmacy (use of multiple medications)

Symptoms

Symptoms can vary widely depending on the substances involved but may include:

  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Neurological effects (dizziness, confusion, altered mental status)
  • Cardiovascular instability (hypotension, arrhythmias)
  • Respiratory distress
  • Skin reactions (rash, itching)
  • Metabolic abnormalities (e.g., electrolyte imbalances)

Diagnosis

Diagnosis relies on clinical evaluation, patient history (including substance exposure details), and laboratory testing to identify the causative agent. Documentation must specify the nature of the event (poisoning, adverse effect, or underdosing) and the substance involved, even if classified as "other." Toxicology screens or specialized tests may be used to confirm exposure.

Treatment Options

Treatment is tailored to the substance, severity, and clinical presentation. It may include decontamination (e.g., activated charcoal), supportive care (e.g., airway management, fluid resuscitation), specific antidotes (if available), and monitoring for complications. Underdosing scenarios require adjusting therapy to achieve therapeutic levels.

Prognosis and Follow-Up

Prognosis depends on the substance, dose, and timeliness of treatment. Early intervention improves outcomes. Follow-up may involve monitoring for delayed effects, adjusting medications, or addressing underlying causes (e.g., substance misuse). Long-term care may be needed for severe cases or complications.

Complications

  • Organ damage (e.g., liver, kidney)
  • Neurological impairment
  • Cardiovascular collapse
  • Respiratory failure
  • Metabolic derangements
  • Psychological sequelae (e.g., anxiety, depression)

Lifestyle & Prevention

  • Store medications securely to prevent accidental ingestion.
  • Follow dosing instructions carefully and avoid self-adjusting prescriptions.
  • Disclose all medications (including over-the-counter and supplements) to healthcare providers.
  • Use childproof containers and educate family members on safe medication practices.
  • Seek help for substance misuse or mental health concerns.

When to Seek Professional Help

Seek immediate medical attention if you experience symptoms of poisoning (e.g., severe nausea, confusion, difficulty breathing) or suspect incorrect dosing. Contact a healthcare provider for persistent adverse effects or unexplained symptoms after starting a new medication.

Tips for Medical Coders

Document the specific nature of the event (poisoning, adverse effect, or underdosing) and the substance involved, even if classified as "other." Ensure clinical details support the use of T50.99, as it applies to substances not covered by more specific codes. Verify that the event is not better described by a narrower code (e.g., for known drugs or biological substances).

Book a walkthrough

T50.99 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.